SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-21-000955
Filing Date
2021-08-05
Accepted
2021-08-05 16:41:36
Documents
64
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q cala-20210630.htm   iXBRL 10-Q 2302369
2 EX-31.1 cala-20210630ex31_1.htm EX-31.1 13596
3 EX-31.2 cala-20210630ex31_2.htm EX-31.2 13251
4 EX-32.1 cala-20210630ex32_1.htm EX-32.1 9160
5 EX-32.2 cala-20210630ex32_2.htm EX-32.2 9059
  Complete submission text file 0000950170-21-000955.txt   7322444

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT cala-20210630_cal.xml EX-101.CAL 39072
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cala-20210630.xsd EX-101.SCH 43445
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cala-20210630_pre.xml EX-101.PRE 272404
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cala-20210630_lab.xml EX-101.LAB 375277
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT cala-20210630_def.xml EX-101.DEF 125842
11 EXTRACTED XBRL INSTANCE DOCUMENT cala-20210630_htm.xml XML 1298861
Mailing Address 343 OYSTER POINT BLVD #200 SOUTH SAN FRANCISCO CA 94080
Business Address 343 OYSTER POINT BLVD #200 SOUTH SAN FRANCISCO CA 94080 650-870-1000
Calithera Biosciences, Inc. (Filer) CIK: 0001496671 (see all company filings)

IRS No.: 272366329 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36644 | Film No.: 211149020
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences